BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18592835)

  • 1. Observations on the mechanism of omalizumab as a steroid-sparing agent in autoimmune or chronic idiopathic urticaria and angioedema.
    Dreyfus DH
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):624-5. PubMed ID: 18592835
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of omalizumab on patients with chronic urticaria: issues with the determination of autoimmune urticaria.
    Sheikh J
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):88; author reply 88-9. PubMed ID: 18254490
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic autoimmune urticaria with omalizumab.
    Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies.
    Chakravarty SD; Yee AF; Paget SA
    J Allergy Clin Immunol; 2011 Dec; 128(6):1354-5. PubMed ID: 21958584
    [No Abstract]   [Full Text] [Related]  

  • 5. Allergy and systemic diseases: the case of chronic urticaria and thyroid disease.
    Rottem M
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):889-90. PubMed ID: 12455173
    [No Abstract]   [Full Text] [Related]  

  • 6. Simultaneous occurrence of chronic autoimmune urticaria and non-allergic asthma: a common mechanism?
    Tedeschi A; Cottini M; Asero R
    Eur Ann Allergy Clin Immunol; 2009 Apr; 41(2):56-9. PubMed ID: 19585861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic autoimmune urticaria: treatment with omalizumab].
    Máspero JF; Parisi CA; De Gennaro M; Benhabib O; Lampert M
    Arch Argent Pediatr; 2009 Oct; 107(5):452-6. PubMed ID: 19809768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an anaphylactoid reaction to omalizumab.
    Dreyfus DH; Randolph CC
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):624-7. PubMed ID: 16680936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of chronic urticaria and angioedema with thyroid autoimmunity.
    Leznoff A; Josse RG; Denburg J; Dolovich J
    Arch Dermatol; 1983 Aug; 119(8):636-40. PubMed ID: 6870316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of urticaria and angioedema].
    Panaszek B
    Pol Merkur Lekarski; 2003 Jun; 14(84):553-6. PubMed ID: 14524269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune urticaria response to high-dose intravenous immunoglobulin.
    Klote MM; Nelson MR; Engler RJ
    Ann Allergy Asthma Immunol; 2005 Feb; 94(2):307-8. PubMed ID: 15765750
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.
    Altman K; Chang C
    Clin Rev Allergy Immunol; 2013 Aug; 45(1):47-62. PubMed ID: 22674016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of omalizumab in delayed pressure urticaria: a case report.
    Bindslev-Jensen C; Skov PS
    Allergy; 2010 Jan; 65(1):138-9. PubMed ID: 19804440
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria.
    Palacios T; Stillman L; Borish L; Lawrence M
    J Allergy Clin Immunol Pract; 2016; 4(3):529-30. PubMed ID: 26725153
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic urticaria/angioedema and Graves' disease: Coexistence of 2 antireceptor antibody-mediated diseases.
    Irani C; Gordon ND; Zweiman B; Levinson AI
    J Allergy Clin Immunol; 2001 Nov; 108(5):874. PubMed ID: 11692119
    [No Abstract]   [Full Text] [Related]  

  • 16. Angioedema is an unfavorable factor for the response to omalizumab in chronic spontaneous urticaria: A retrospective study.
    Serarslan G; Uzun M; Doğramacı AÇ; Çelik E
    Dermatol Ther; 2019 Jan; 32(1):e12752. PubMed ID: 30238582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of omalizumab in cholinergic urticaria.
    Sabroe RA
    Clin Exp Dermatol; 2010 Jun; 35(4):e127-9. PubMed ID: 19925484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients.
    Leznoff A; Sussman GL
    J Allergy Clin Immunol; 1989 Jul; 84(1):66-71. PubMed ID: 2754146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic urticaria with alterations of the thyroid function and thyroid peroxidase antibodies].
    Fernandez Romero DS; Malbran A
    Medicina (B Aires); 2005; 65(3):231-4. PubMed ID: 16042134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab also successful in chronic urticaria.
    Spector SL; Tan RA
    J Allergy Clin Immunol; 2008 Mar; 121(3):784; author reply 784-5. PubMed ID: 18328900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.